Why Intuitive Surgical Stock Dropped This Week

Intuitive Surgical (ISRG) dropped this week after management declined to raise full-year guidance following its Q2 earnings report, despite posting 19% revenue growth and 25% adjusted net income growth that topped Wall Street estimates. The decision to hold guidance flat signals management expects a deceleration in growth for the remainder of 2024.

Multiple analysts responded to the cautious outlook by cutting price targets on the stock. The sell-off came even as the medical robotics company delivered strong second-quarter results, underscoring how sensitive the market has become to forward guidance in the current environment.

The revenue and adjusted net income gains reflect continued adoption of Intuitive's da Vinci surgical systems, but investors are now recalibrating expectations based on management's conservative stance. The company's refusal to lift full-year targets despite beating quarterly numbers suggests potential headwinds in procedure volumes or pricing power.